Longstanding bottleneck in crystal structure prediction solved

Two years after its release, the HIV-1 drug Ritonavir was pulled from the market. Scientists discovered that the drug had crystallized into a slightly different form--called a polymorph--that was less soluble and made it ineffective as a treatment.